NASDAQ · Biotechnology

NTRB (NTRB) Stock

$3.11 +6.69% NASDAQ: NTRB Healthcare

Valuation

MetricValue
Price$3.11
Market Cap$37.81M
P/E Ratio-1.40
P/B Ratio6.25
P/S Ratio20.41
EPS (TTM)$-2.58
52-Week High$11.68
52-Week Low$2.88
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-114.29%
ROA-100.00%
ROCE-114.29%
Gross Margin-400.00%
Operating Margin-400.00%
Net Margin-4.04%
Debt/Equity0.03
Current Ratio5.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$2.0M$2.0M$2.0M$2.0M
Operating Profit$-4.0M$-4.0M$-5.0M$-7.0M$-8.0M
Net Profit$-8.0M$-5.0M$-5.0M$-10.0M$-8.0M
EPS$-1.06$-0.57$-0.69$-0.99$-2.58
Op Margin-276.3%-199.4%-233.6%-312.6%-408.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.0M$9.0M$8.0M$7.0M$8.0M
Total Liabilities$1.0M$1.0M$1.0M$1.0M$1.0M
Cash$5.0M$2.0M$0$4.0M$5.0M
Borrowings$0$0$0$0$0

Latest News

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference GlobeNewswire · May 15, 2026 Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast GlobeNewswire · Apr 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-3.0M$-4.0M$-5.0M$-5.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$3.0M$0$0$0$0
Net Cash Flow$5.0M$-3.0M$-1.0M$4.0M$0
Free Cash Flow$-3.0M$-3.0M$-4.0M$-5.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-12.34%
Quick Ratio6.21
Interest Coverage—
Return 1Y-62.89%
Return 3Y-7.12%
Return 5Y—

Ownership

Insiders Held56.81%
Institutions Held3.08%
Institutions Float Held7.13%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC174,9272026-03-31
Geode Capital Management, LLC70,0532026-03-31
UBS Group AG32,6642026-03-31
Vanguard Fiduciary Trust Co25,1112026-03-31
State Street Corporation24,9662026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACET $8.30 +1.22% -0.46 $77.59M 0.00%
ACRV $1.73 +2.37% -0.95 $74.05M 0.00%
ADAGAdagene Inc. $3.67 +1.66% -7.78 $138.17M 0.00%
CRVO $2.56 -3.76% -1.09 $23.70M 0.00%
FBIO $2.67 -3.61% 0.91 $88.69M 0.00%

About NTRB

NTRB is led by CEO Gareth Sheridan, employs 13 people, headquartered in US, publicly traded since 2021.

NTRB stock trades at $3.11 with a market capitalization of $37.81M. The stock is valued at a price-to-earnings (P/E) ratio of -1.40, price-to-book of 6.25, price-to-sales of 20.41. Over the past 52 weeks the stock has ranged between $2.88 and $11.68, and currently trades 73.4% below its 52-week high.

On profitability, NTRB generates a return on equity (ROE) of -114.29%, return on capital employed of -114.29%, an operating margin of -400.00%, a net profit margin of -4.04%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides